Trial
NCT04698187
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Regeneron Pharmaceuticals
Collaborators
Bristol-Myers Squibb
Condition
Melanoma
Intervention
CMP-001
Why stopped
Business Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-11